In latest news, MMXXII Mundus artificialis intelligentia colloquium (Waic MMXXII) calce off in mane Septembris I ad Shanghai mundo turpis. Hoc captiosus conferentia erit focus in quinque elementa "Humanity, technology, industria, urbem, et futurum" et accipe "Meta" quod est ad breakthrough ad penitus interpretationem in thema "intelligens connected mundi, originali vita absque terminis". In penetratione AI technology in omnes ambulat vitae, digital applications in medicinae et pharmaceutical agros sunt magis et magis in-profundum et diverse, auxilio morbo praeventionis, periculo taxationem, surgery, medicamento curatio et medicamento vestibulum et productio.

Inter eos, in medical agro, quod attrahit operam est "intelligentes recognitionem algorithm et systema pueritia leukemia cell Morphology." Usus artificialis intelligentia imaginem recognition technology ut adiuvaret in diagnosis de Leukemia; In Endoscopic chirurgicam robot developed per minime Psidium medical potest applicari ad variis difficile urological surgeries; In ingenio artificialis Innovation Platform, worted by 5G, nubes computing, et magnum notitia technology, tries medicinae imaginatione AI investigationis et progressionem est integrated in scaenam et scale; GE aedificavit medicando imaginatione progressionem et applicationem suggestus secundum quatuor core modules.

Nam Pharmaceutical Industry, Shanghai Iven Pharmaceutical Engineering Co., Ltd. habet etiam comprehensively upgraded pharmaceutical machinatione a vestibulum ut "intelligentes vestibulum." Cum potestate "intelligentia", Iven utitur "simpliciorem" apparatu et personalized solutions ad consequi optimum procuratio pro pharmaceutical turmas. Cum magis severus requisita GMP et aliis ordinationibus, traditional modo potest non praestet obsequio de ordinationibus. IVEN's implementation of intelligent manufacturing, on the one hand, will help ensure the data integrity of the enterprise, improve process control capabilities and production efficiency, and improve the intelligence of the production process, thereby ensuring GMP compliance, ensuring product quality and safety, reducing enterprise operating costs, and ensuring the survival and development of enterprises. In alia manu, ien iuvat pharmaceutical turmas "amplio qualitas, crescere varietates, et creare brands" per layout intelligentes vestibulum.

Hoc ostendit quod progressionem artificialis intelligentia est ingressus novum scaena. Per designing provectus algorithms, integrating quantum notitia fieri potest, pooling magna moles computing potestate et intensive disciplina magna exempla servire magis conatibus.
In futuro, Evan credit quod clavem verba ad progressionem de pharmaceutical industria erit "integration", "extensio" et "innovation". Ideo in Core negotium nunc est ut scaena idoneam ad AI ad ludere maximum valorem, ut possit melius servire humana salute, captis innovatio ornare pro pharmaceutical industria, capere innovatio et altum cogitandi, et amplio gubilibus et altum.